ASLAN Pharmaceuticals Limited stock is up 25.88% since 30 days ago. The next earnings date is Mar 22, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 March’s closed higher than February.
ASLAN Pharmaceuticals Limited is a clinical-stage immunology focused biopharmaceutical company. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications. ASLAN003 is a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!